Literature DB >> 25216870

High percentage of α1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer.

Xiao Qu1, Zhaofei Pang, Weiwei Yi, Ying Wang, Kai Wang, Qi Liu, Jiajun Du.   

Abstract

The association of the percentage composition of serum protein in patients undergoing lung resections for non-small cell lung cancer (NSCLC) with overall survival and recurrence-free survival has never been investigated. Patients were selected consecutively from the database of the Bio-Bank of Shandong Provincial Hospital. We retrospectively examined the impact of preoperative percentage composition of serum protein detected by serum protein electrophoresis on survival. Furthermore, we investigated the relationships between the potential prognostic biomarkers and clinicopathological factors. A total of 390 patients were evaluated. The higher percentage of α1-globulin in serum protein was significantly associated with histology type (p<0.001), worse tumor status (p<0.001) and higher pathological stage (p=0.004). The α1-globulin percentage composition was an independent prognostic factor for overall survival (hazard ratio 1.52, 95% CI 1.04-2.23, p=0.03). High percentage of α1-globulin in serum protein was also related to short recurrence survival (hazard ratio 1.56, 95% CI 1.14-2.13, p=0.005). Our results showed that the percentage of α1-globulin in serum protein may be an independent prognostic factor in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25216870     DOI: 10.1007/s12032-014-0238-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  33 in total

Review 1.  Understanding and interpreting serum protein electrophoresis.

Authors:  Theodore X O'Connell; Timothy J Horita; Barsam Kasravi
Journal:  Am Fam Physician       Date:  2005-01-01       Impact factor: 3.292

2.  Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells.

Authors:  J Cichy; J Potempa; J Travis
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

Review 3.  Alpha1-antitrypsin deficiency: biological answers to clinical questions.

Authors:  R J Coakley; C Taggart; S O'Neill; N G McElvaney
Journal:  Am J Med Sci       Date:  2001-01       Impact factor: 2.378

4.  Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.

Authors:  Naohiro Kobayashi; Shingo Usui; Shinji Kikuchi; Yukinobu Goto; Mitsuaki Sakai; Masataka Onizuka; Yukio Sato
Journal:  Lung Cancer       Date:  2011-07-20       Impact factor: 5.705

5.  Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival.

Authors:  Yan Li; Michael J Krowka; Yingwei Qi; Jerry A Katzmann; Yong Song; Yafei Li; Sumithra J Mandrekar; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

6.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

7.  Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis.

Authors:  Wei Zhao; Zhen Yang; Xingchen Liu; Qing Tian; Yongzhuang Lv; Yuan Liang; Chunsun Li; Xiaofang Gao; Liangan Chen
Journal:  J Int Med Res       Date:  2013-04-23       Impact factor: 1.671

8.  Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.

Authors:  Liming Sheng; Min Luo; Xiaojiang Sun; Nengming Lin; Weimin Mao; Dan Su
Journal:  Int J Cancer       Date:  2013-06-14       Impact factor: 7.396

9.  Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.

Authors:  T T Pelliniemi; K Irjala; K Mattila; K Pulkki; A Rajamäki; A Tienhaara; M Laakso; R Lahtinen
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

10.  An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

View more
  7 in total

1.  Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

Authors:  Xiang Chen; JiaXi Yao; Li Liu; WenZhong Zheng; XiaoYi Hu; YanJun Zhu; Hang Wang; JianMing Guo
Journal:  Target Oncol       Date:  2019-04       Impact factor: 4.493

2.  A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.

Authors:  Li-Xiang Zhang; Lei Chen; A-Man Xu
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

3.  An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.

Authors:  Ying Wang; Xiao Qu; Ngar-Woon Kam; Kai Wang; Hongchang Shen; Qi Liu; Jiajun Du
Journal:  BMC Cancer       Date:  2018-06-26       Impact factor: 4.430

4.  Prognostic value of preoperative albumin to globulin ratio in elderly patients with rectal cancer.

Authors:  Yixin Xu; Xuezhong Xu; Cheng Xi; Nianyuan Ye; Yibo Wang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Prognostic Values of Systemic Inflammation Response (SIR) Parameters in Resectable Cervical Cancer.

Authors:  Wen-Jie Wang; Ying Li; Jie Zhu; Min-Jie Gao; Jian-Ping Shi; Yue-Qing Huang
Journal:  Dose Response       Date:  2019-02-26       Impact factor: 2.658

6.  Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy.

Authors:  Zhuo Wang; Liqun Zhang; Jingyan Wang; Yuanhe Wang; Qian Dong; Haiyan Piao; Qiwei Wang; Jingdong Zhang
Journal:  J Immunol Res       Date:  2020-08-05       Impact factor: 4.818

7.  Sodium to globulin ratio as a prognostic factor for patients with advanced gastric cancer.

Authors:  Liqun Zhang; Zhuo Wang; Jiawen Xiao; Hao Chen; Zhiyan Zhang; Haijing Li; Yuanhe Wang; Haiyan Piao; Fang Li; Lisha Zhang; Jingdong Zhang
Journal:  J Cancer       Date:  2020-10-23       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.